Carson Wealth (CWM LLC)’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
VCM
MCM
TSC
PCM
Carson Wealth (CWM LLC)'s LUCD Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Lucid Diagnostics (LUCD) stake by 423% in Q1 2026, buying an estimated $17.4K and bringing the position to 16,940 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4433.
Carson Wealth (CWM LLC) first reported a position in LUCD in Q4 2021 and has held it in 16 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.
- Carson Wealth (CWM LLC) held 16,940 shares of Lucid Diagnostics worth $19.5K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 13,700 Lucid Diagnostics shares in Q1 2026, an estimated $17.4K.
- Lucid Diagnostics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4433 holding.
- Carson Wealth (CWM LLC) first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 16 quarters since.
- 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.